Buy Enalapril

Enalapril

Introduction

Enalapril is an oral pill that contains Enalapril Maleate as its active component. It belongs to the heart and blood-pressure therapeutic class and is available in strengths of 2.5 mg, 5 mg, and 10 mg. In Hong Kong, Enalapril is a prescription-only medication regulated by the Pharmacy and Poisons Board of the Department of Health. The drug is marketed in various brand names worldwide, but all formulations share the same active ingredient and pharmacologic profile.

How Enalapril Works in the Body

Enalapril is an angiotensin-converting enzyme (ACE) inhibitor. After oral ingestion, the pro-drug enalapril is rapidly converted by hepatic enzymes to its active form, enalaprilat. Enalaprilat blocks the ACE enzyme, which normally transforms angiotensin I into the potent vasoconstrictor angiotensin II. By reducing angiotensin II levels, Enalapril :

• Dilates blood vessels, lowering systemic vascular resistance.
• Decreases aldosterone secretion, promoting sodium and water excretion.
• Reduces sympathetic tone, contributing to lower heart rate and blood pressure.

The combined effect leads to a gradual reduction in blood pressure and diminishes the workload on the heart, which is why Enalapril is useful in treating hypertension and certain forms of heart failure.

Conditions Treated by Enalapril

Enalapril is approved by regulatory agencies in Hong Kong (and internationally) for the following indications:

• Primary hypertension (high blood pressure).
• Congestive heart failure with reduced ejection fraction, as part of a comprehensive regimen.
• Asymptomatic left-ventricular dysfunction following a myocardial infarction (to improve survival).

These uses are based on large-scale clinical trials demonstrating that ACE inhibition improves morbidity and mortality in the listed conditions.

Patient Suitability and Contraindications

Who Should Not Use Enalapril?

• Absolute contraindications
• Known hypersensitivity to enalapril, enalaprilat, or any excipients in the pill.
• History of angio-edema related to previous ACE-inhibitor therapy.
• Pregnancy (particularly the second and third trimesters) because of risk to the fetus.
• Relative contraindications
• Severe renal impairment (eGFR < 30 mL/min/1.73 m²) unless benefits outweigh risks.
• Hyperkalemia (serum potassium > 5.5 mmol/L).
• Concomitant use of aliskiren in patients with diabetes or renal dysfunction.

Special populations such as the elderly may require lower starting doses due to altered pharmacodynamics. Women who are pregnant or planning pregnancy should avoid Enalapril.

Safety Profile

Common Side Effects

• Dry cough (often described as “tickle” in the throat).
• Dizziness or light-headedness, especially after the first few doses.
• Fatigue or mild weakness.

These effects are usually transient and may diminish as the body adjusts to the medication.

Serious Adverse Events

• Angio-edema involving the face, lips, tongue, or airway (requires immediate medical attention).
• Significant hyperkalemia that can cause cardiac arrhythmias.
• Acute kidney injury, manifested by a sudden rise in serum creatinine (>30 % increase from baseline).

If any of these severe reactions occur, discontinue Enalapril promptly and seek emergency care.

Drug Interactions

• Major interactions
• Potassium-sparing diuretics (e.g., spironolactone) or supplements can precipitate dangerous hyperkalemia.
• Non-steroidal anti-inflammatory drugs (NSAIDs) may blunt antihypertensive efficacy and increase renal risk.
• Moderate interactions
• Other antihypertensives (e.g., diuretics, calcium-channel blockers) often require dose adjustment to avoid excessive blood pressure lowering.
• Lithium levels may rise, necessitating close monitoring.

Enalapril is metabolised through the hepatic pathway but does not significantly inhibit or induce common cytochrome P450 enzymes, limiting pharmacokinetic interactions.

Food and Lifestyle Interactions

• The pill can be taken with or without food; however, taking it with a light snack may reduce occasional stomach upset.
• Alcohol can augment blood-pressure-lowering effects and increase dizziness; moderation is advised.
• Patients should avoid using high-potassium salt substitutes without professional guidance.

Driving or operating heavy machinery is generally safe once the patient’s blood pressure stabilises, but caution is advised during the initial dosing period.

How to Take Enalapril

• Standard dosing

• Initial dose for hypertension: 5 mg once daily.

• For heart failure: 2.5 mg once daily, titrated upward based on tolerance and clinical response, up to a maximum of 20 mg per day (split into 10 mg twice daily if needed).

• Available pill strengths are 2.5 mg, 5 mg, and 10 mg; tablets should be swallowed whole with a glass of water.

• Special populations

• Renal impairment: Start at 2.5 mg daily; adjust according to eGFR and serum creatinine trends.

• Elderly: Consider a 2.5 mg starting dose, especially if volume-depleted or on multiple antihypertensives.

• Missed dose

• Take the missed tablet as soon as remembered unless it is near the time of the next scheduled dose; do not double up.

• Overdose

• Symptoms may include profound hypotension, dizziness, and renal dysfunction. Seek emergency medical care; treatment is supportive with intravenous fluids and vasopressors if needed.

• Discontinuation

• Abrupt cessation is generally safe, but for heart-failure patients a gradual taper may minimise symptom rebound.

Monitoring and Follow-Up

• Blood pressure: Check within 1-2 weeks after initiation, then at regular intervals to ensure target levels are achieved.
• Renal function: Serum creatinine and eGFR should be measured before starting therapy and within 1-2 weeks after dose changes.
• Electrolytes: Serum potassium should be monitored, especially in patients on diuretics, supplements, or with renal disease.

Routine follow-up appointments allow the prescriber to fine-tune dosing and assess for adverse effects.

Storage and Handling

• Store the pills at room temperature (20-25 °C/68-77 °F) away from direct sunlight and moisture.
• Keep the container tightly closed and out of reach of children.
• Do not use tablets that are discoloured, cracked, or past the expiration date noted on the package.
• Dispose of unused medication according to local pharmaceutical waste guidelines or return to a pharmacy-based take-back program.

Medication-Specific Glossary

ACE inhibitor

A class of drugs that block the angiotensin-converting enzyme, reducing the formation of angiotensin II and lowering blood pressure.

Angiotensin-II

A peptide hormone that narrows blood vessels, raises blood pressure, and stimulates aldosterone release.

Bradykinin

A vasoactive peptide that accumulates when ACE is inhibited, contributing to the characteristic dry cough of ACE inhibitors.

Renin-angiotensin-aldosterone system (RAAS)

A hormonal cascade that regulates blood pressure, fluid balance, and electrolyte homeostasis; ACE inhibitors act on this system to produce antihypertensive effects.

Enalaprilat

The active metabolite formed from enalapril after hepatic conversion; it directly inhibits ACE.

Medical Disclaimer

This article provides educational information about Enalapril and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.